Target intelligence / Profile preview

Neuropeptide FF receptor 2 (NPFFR2) (NPFFR2)

Target
NPFFR2
Molecular classification
G protein-coupled receptor, Receptor
01

Overview

Neuropeptide FF receptor 2 (NPFFR2), also known as GPR74, is a G protein-coupled receptor (GPCR) primarily expressed in the central nervous system, with high density in the superficial layers of the spinal cord and the hypothalamus. It is activated by endogenous RF-amide neuropeptides, particularly neuropeptide FF (NPFF) and neuropeptide AF (NPAF). NPFFR2 plays a critical role in nociception and pain modulation, acting as a key regulator of the opioid system. Depending on the site of administration, activation of NPFFR2 can either potentiate or antagonize opioid-induced analgesia, and it is heavily implicated in the development of opioid tolerance and opioid-induced hyperalgesia.

Beyond its role in pain, NPFFR2 is involved in central autonomic regulation, including the control of body temperature, heart rate, and energy homeostasis. Pharmacological targeting of NPFFR2 with antagonists represents a promising therapeutic strategy to enhance the efficacy of opioid analgesics while mitigating side effects like tolerance and dependence. Additionally, genetic studies link NPFFR2 to metabolic regulation, suggesting its potential as a target for obesity and related metabolic disorders.

Other names
G-protein coupled receptor 74GPR74HLWAR77NPFF2NPGPRNeuropeptide G-protein coupled receptor
02

Mechanism of action

Neuropeptide FF receptor 2 antagonism or agonism

03

Biological functions

Signal transductionNociceptionNeuropeptide signaling pathwayRegulation of MAPK cascadeRegulation of adenylate cyclase activityThermoregulationEnergy homeostasis
04

Disease associations

PainInflammationObesityDrug dependenceOther
05

Safety considerations

Opioid toleranceOpioid-induced hyperalgesiaAltered pain sensitivityCardiovascular effects (tachycardia, increased blood pressure)Body temperature dysregulation (hyperthermia)Metabolic dysregulation (obesity, glucose intolerance)
06

Interacting drugs

RF9

8 more in the full profile.

07

Biomarkers

NPFFR2 expression levels

Beyond the preview

Go deeper on Neuropeptide FF receptor 2 (NPFFR2) (NPFFR2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuropeptide FF receptor 2 (NPFFR2) (NPFFR2).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call